Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Herb-based Supplements and Hemp-based Cannabidiol
100.0
%
| 16 | 100.0 % | 16 | 100.0 % | -1.24% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 16 | 100.0 % | -1.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 14-06-15 |
Joerg Grasser
DFI | Director of Finance/CFO | 49 | 18-12-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 66 | 14-06-15 |
Jamie Corroon
BRD | Director/Board Member | 54 | 22-07-20 |
William McCorkle
BRD | Director/Board Member | 56 | 22-10-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 163,228,469 | 163,197,469 ( 99.98 %) | 0 | 99.98 % |
Stock B | 0 | 1,000 | 0 | 0 |
Company contact information
CV Sciences, Inc.
9530 Padgett Street Suite 107
92126, San Diego
+866 290 2157
http://www.cvsciences.comSector
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |